Latest news
Emcure to double down on complex generics, biosimilars, ARVs, says COO Samit Mehta - TradingViewTradingView · Mon, 10 Aug 2026 07:05:30 GMTEmcure Q1 revenue rises 23% to ₹2,580 cr; names Samit Mehta new COO - ET PharmaET Pharma · Fri, 07 Aug 2026 09:41:25 GMTEmcure Pharma net profit up 36% at Rs 292 crore - The Economic TimesThe Economic Times · Thu, 06 Aug 2026 19:41:35 GMTEmcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO - The Economic TimesThe Economic Times · Thu, 06 Aug 2026 16:50:19 GMTEmcure Pharmaceuticals Q1 Results: Net profit rises 42%, international business aids topline growth - indiaipo.inindiaipo.in · Thu, 06 Aug 2026 10:38:03 GMTEmcure appoints Raghu Kumar as independent director, Satish Mehta set to become chairman - scanx.tradescanx.trade · Thu, 06 Aug 2026 09:02:37 GMTEmcure Pharmaceuticals sees 36% PAT rise, appoints new COO - scanx.tradescanx.trade · Thu, 06 Aug 2026 08:51:40 GMT